This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.Find sources: "Hypoxia preconditioned plasma" – news · newspapers · books · scholar · JSTOR (April 2023) (Learn how and when to remove this template message)
Image of a prototype bioreactor device for one-step preparation and sampling of Hypoxia Preconditioned Plasma (HPP)

Hypoxia preconditioned plasma or hypoxia pre-conditioned plasma (abbreviated as HPP) is the (cell-free) plasma obtained after extracorporeal conditioning (i.e. culturing) of anticoagulated blood under physiological temperature (37 °C) and physiological hypoxia (1–5 %O2). Blood conditioning is typically carried out over 2 to 4 days.

No high quality evidence supports its use for any medical purpose as of 2016.[1]

References

  1. ^ Steinhoff, Gustav (2016). Regenerative Medicine - from Protocol to Patient: 5. Regenerative Therapies II. Springer. p. 377. ISBN 9783319283869.
Categories